- Home
- Services
- usa california
- oncologist
Refine by
Oncologist Services In Usa California
24 services found
by:Natera, Inc. based inAustin, TEXAS (USA)
Your Oncology Support Resource. At Natera, a test is more than just a test; it’s part of an integrated experience, built around a core suite of services to support patients and providers and to make testing ...
Manufactured by:Ultima Genomics based inFremont, CALIFORNIA (USA)
Our Technology Access Program offers accessible entry to the UG 100™ through our in-house applications lab. Sequence on our high-capacity fleet of UG 100 Sequencers and receive support at every step, from consultation through data analysis. Connect ...
Manufactured by:Molecular Devices, LLC. based inSan Jose, CALIFORNIA (USA)
PDO end use applications include organ-on-a-chip, high throughput compound screening, 3D high content image analysis and applications in complex in-vitro assays for ...
by:Nautilus Biotechnology based inSeattle, WASHINGTON (USA)
At Nautilus, our philosophy is to engage with the broader scientific community and utilize our technology and expertise to enable novel, high impact, proteomic discoveries. We are now providing access to our technology for a select group of collaborators. Currently, we are exploring research across a wide range of fields, including oncology, neuroscience, infectious disease, immunology, and ...
by:Amgen Inc. based inThousand Oaks, CALIFORNIA (USA)
We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Our medicines typically address diseases for which there are limited treatment options, or they are ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro’s clinical capabilities span from early phase, first-in-human through late phase and post-approval studies. We focus on studies containing imaging and pathology-based endpoints requiring robust, independent assessments to ascertain drug efficacy. Our imaging core lab and CAP/CLIA lab-based pathology services solutions support various therapeutic areas including oncology, ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Why partner with Signatera for your clinical trial? Clinically validated across multiple solid tumors, Signatera has shown to predict relapse in >98% of patients without further treatment. Experienced team with Global reach: CE Mark, three FDA Breakthrough Device Designations, 8 Non-Significant Risk (NSR) determinations. >60 Natera IP assets covering ctDNA MRD and ...
Manufactured by:Sangamo Therapeutics based inBrisbane, CALIFORNIA (USA)
Sangamo is using groundbreaking science and novel technology to replace today’s symptomatic treatments with tomorrow’s genomic cures. We are pursuing programs across the spectrum of genomic medicine, with gene and cell therapies in the clinic today and preclinical programs in genome engineering and off-the-shelf cell therapy. Behind these are research efforts thoughtfully focused on ...
Manufactured by:Veracyte, Inc. based inSouth San Francisco, CALIFORNIA (USA)
Veracyte offers customized biomarker testing and analytical services to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs. We do this by leveraging our novel insights into the molecular underpinnings of disease and our extensive experience in drug development. Our immuno-oncology offerings focus on the implications of the ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
TCR profiling holds great potential not only for understanding the mechanisms of development of the normal immune response, but also in providing insights into disease mechanisms and development of new therapeutics and treatment modalities in infectious diseases, autoimmunity and in immuno-oncology. However, identification of all potential clonotypes in a diverse repertoire of TCRs requires ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro is an medical imaging CRO with over 210 scientists, 60+ PhD’s and MD’s and 2100+ qualified imaging centers across the globe. We possess scientific and regulatory expertise, project management scale and operational excellence to manage all the clinical trial imaging components of your Phase I-IV clinical trials across the therapeutic spectrum and spanning imaging ...
Manufactured by:Novartis International AG based inBasel, SWITZERLAND
We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, restore possibility and help people live life on their own terms. Researchers in Biomedical Research work across several diseases areas to uncover insights into the origins and pathogenesis of ...
Manufactured by:miraDry, Inc. based inNewport Beach, CALIFORNIA (USA)
Products and Procedures miraDry, Inc. proprietary miraWave™ technology utilizes microwave energy to precisely deliver energy to target areas. The use of microwave energy has been long established in various fields of medicine from oncology to urology; however, miraDry, Inc. is the first to harness this energy for use in applications in Dermatology and Plastic ...
Manufactured by:Kura Oncology, Inc. based inSan Diego, CALIFORNIA (USA)
Kura Oncology’s clinical trial programs represent the next step toward our goal of realizing the full potential of precision medicine. Our investigational trials are studying innovative therapeutic candidates with the potential to help patients with certain cancers live better, longer lives. ...
by:xCures based inOakland, CALIFORNIA (USA)
xCures’ patient-centric focus ensures that advanced cancer patients continuously engage with the xCures platform. Patients and their treating physicians receive decision support and access to leading therapeutics and diagnostics in return for ongoing access to their electronic medical records throughout their cancer journey. This direct patient engagement yields continuous, prospective Real ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study has enrolled approximately 15,000 participants across 142 sites in the United States and Canada, and includes ...
by:CureMatch, Inc. based inSan Diego, CALIFORNIA (USA)
CureMatch provides a scored and ranked listing of the most well-adapted personalized medicine treatment options. The comprehensive analysis considers commonly used treatments, as well as targeted therapy, immunotherapy, hormone therapy, and newly approved oncology drugs. These options are presented either alone (monotherapy) or in combinations of up to 4 ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
Profiling the Tumor Microenvironment: Using a genomics based approach to analyze the tumor microenvironment can provide unique insights beyond IHC and FACS methods. OncoPeptTUME deeply interrogates RNA-Seq data sets to produce high resolution mapping of the tumor microenvironment using proprietary cell type specific gene expression signatures. OncoPeptTUME provides a critical assessment of the ...
Manufactured by:BioAssay Systems based inHayward, CALIFORNIA (USA)
BioAssay Systems offers a wide range of services for analyzing biological samples. Our services can take care of everything from sample preparation such as tissue homogenization and sample extraction to interpreting the data and full scientific analysis of the experimental results. The majority of our assays are not species specific so we are capable of performing analyses on biological samples ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...